Pylarify was Lantheus Holdings’s largest product and service line in fiscal 2025, bringing in $989.12M of $1.54B (64%).
| Product and Service | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pylarify | $527.41M | $851.30M | $1.06B | $989.12M | |||||||||
| Definity | $244.99M | $279.77M | $317.79M | $330.25M | |||||||||
| D E F I N I T Y | — | — | — | — | |||||||||
| Technelite | $88.86M | $87.37M | $95.49M | $86.80M | |||||||||
| Techne Lite | — | — | — | — | |||||||||
| Other Nuclear | — | — | — | — | |||||||||
| Other | — | — | — | — | |||||||||
| Other Products | — | — | — | — | |||||||||
| Neuraceq | — | — | — | $51.45M | |||||||||
| Xenon | — | — | — | — | |||||||||
| Strategic Partnerships & Other Revenue | $46.87M | $51.88M | $38.18M | $59.38M | |||||||||
| Other Precision Diagnostics | $22.83M | $22.98M | $24.23M | $24.62M | |||||||||
| Other Radiopharmaceutical Oncology | $4.10M | $3.13M | $384.00K | — | |||||||||
| Rebates & Allowances | — | — | — | — | |||||||||
| Total | $935.06M | $1.30B | $1.53B | $1.54B |
Lantheus Holdings brought in $1.54B from its six product and service lines in fiscal 2025, the year ended December 31, 2025. Lantheus Holdings regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $1.53B. Pylarify was the largest at $989.12M (64.2%), ahead of Definity at $330.25M (21.4%) and Technelite at $86.80M (5.6%). The other three lines brought in $135.44M combined.
Compared with fiscal 2024, Strategic Partnerships & Other Revenue grew fastest, up 55.5% to $59.38M, while Technelite fell the most, down 9.1% to $86.80M.
Lantheus Holdings began breaking out Neuraceq in fiscal 2025, when it brought in $51.45M. Lantheus Holdings stopped reporting Other Radiopharmaceutical Oncology as a separate line after fiscal 2024, when it brought in $384.00K.
United States was Lantheus Holdings’s largest region in fiscal 2025, bringing in $1.46B of $1.54B (95%).
| Geography | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| United States | $1.26B | $1.48B | $1.46B | ||||||
| U.S | — | — | — | ||||||
| Rest Of World | $34.28M | $49.22M | $82.73M | ||||||
| All Other | — | — | — | ||||||
| Canada | — | — | — | ||||||
| Total | $1.30B | $1.53B | $1.54B |
Lantheus Holdings brought in $1.54B from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 0.5% from $1.53B in fiscal 2024. United States was the largest at $1.46B (94.6%), ahead of Rest Of World at $82.73M (5.4%).
Compared with fiscal 2024, Rest Of World grew 68.1% to $82.73M, while United States fell 1.7% to $1.46B. From fiscal 2023 to 2025, combined revenue from these regions grew from $1.30B to $1.54B, a compound annual growth rate of 9.0%. United States' share of the total fell from 97.4% to 94.6%.
U.S was Lantheus Holdings’s largest segment in fiscal 2018, bringing in $288.58M of $343.37M (84%).
| Segment | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 |
|---|---|---|---|---|---|---|
| U.S | $235.82M | $257.42M | $290.00M | $288.58M | ||
| International | $57.64M | $44.43M | $41.38M | $54.79M | ||
| Inter-Segment | — | — | — | — | ||
| Total | $293.46M | $301.85M | $331.38M | $343.37M |
Lantheus Holdings brought in $343.37M from its two segments in fiscal 2018, the year ended December 31, 2018. That was up 3.6% from $331.38M in fiscal 2017. U.S was the largest at $288.58M (84.0%), ahead of International at $54.79M (16.0%).
Compared with fiscal 2017, International grew 32.4% to $54.79M, while U.S fell 0.5% to $288.58M. From fiscal 2015 to 2018, combined revenue from these segments grew from $293.46M to $343.37M, a compound annual growth rate of 5.4%. U.S's share of the total rose from 80.4% to 84.0%.
Lantheus Holdings (LNTH) reports its revenue by product and service, by geography and by segment. In fiscal 2025, Pylarify was its largest product and service line, bringing in $989.12M (64.2% of the total), followed by Definity at $330.25M (21.4%).
Pylarify was Lantheus Holdings' largest product and service line in fiscal 2025, bringing in $989.12M, or 64.2% of the $1.54B total across its six product and service lines.
United States was Lantheus Holdings' largest region in fiscal 2025, bringing in $1.46B, or 94.6% of the $1.54B total across its two regions.
U.S was Lantheus Holdings' largest segment in fiscal 2018, bringing in $288.58M, or 84.0% of the $343.37M total across its two segments.
Rest Of World grew faster than United States in fiscal 2025, up 68.1% from $49.22M to $82.73M. United States fell 1.7% to $1.46B.
Every figure comes from Lantheus Holdings' annual financial filings, as reported. Each line keeps the name Lantheus Holdings gives it, and years follow its fiscal calendar.
Lantheus Holdings' revenue by product and service goes back to fiscal 2013, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.